A single place mutation, V6A, released into the molecule significantly enhanced the toxicity profile and diminished VLS compared to the WT molecule [76]. Further reports and medical trials will likely be needed to determine if this modified build has improved security and efficacy in individuals.Tregs: T regulatory cells; TME: tumor microenvironmen